Complete Genome Sequencing of a Novel Pseudomonas aeruginosa Phage, UF_RH5

Abdolrazagh Hashemi Shahraki1, Majid Vahed1, Roshan Dinparastisaleh1

  • 1Division of Pulmonary, Critical Care and Sleep, College of Medicine-Jacksonville, University of Florida, Gainesville, Florida, USA.

Insights

Researchers discovered UF_RH5, a new lytic bacteriophage effective against Pseudomonas aeruginosa. This Siphovirus family phage has a genome of 42,566 bp and specific morphological characteristics. It offers potential for combating bacterial infections.

Area of Science:

  • Microbiology
  • Virology
  • Bacteriophage research

Background:

  • Pseudomonas aeruginosa is a significant opportunistic pathogen causing various infections.
  • The rise of antibiotic resistance necessitates alternative therapeutic strategies.
  • Bacteriophages offer a promising alternative or adjunct to conventional antibiotics.

Purpose of the Study:

  • To introduce and characterize UF_RH5, a novel lytic bacteriophage.
  • To assess UF_RH5's efficacy against clinical isolates of Pseudomonas aeruginosa.
  • To provide detailed genomic and morphological data of the new phage.

Main Methods:

  • Isolation and characterization of a novel lytic bacteriophage, UF_RH5.
  • Genomic sequencing and analysis of the UF_RH5 genome (42,566 bp, 53.60% GC content).
  • Electron microscopy to determine UF_RH5's morphology (121 nm length, 45 nm capsid).

Main Results:

  • UF_RH5 was identified as a novel lytic phage targeting Pseudomonas aeruginosa.
  • The phage genome encodes 58 proteins.
  • Morphological analysis revealed a Siphovirus family structure.

Conclusions:

  • UF_RH5 represents a new potential therapeutic agent against Pseudomonas aeruginosa infections.
  • Detailed characterization provides a foundation for further development and application.
  • This discovery contributes to the growing field of phage therapy.